Filing Flows › Zymeworks (ZYME) › Q1 2025
Zymeworks (ZYME) Q1 2025 earnings results (first quarter 2025)
10-Q filed May 8, 2025
Zymeworks (ZYME) reported revenue of $27.1M for the first quarter 2025 (Q1 2025), +170% from a year earlier and -13% from the quarter before. Operating margin was -94.5%, net loss $22.6M (83.5% of revenue).
Zymeworks, Q1 2025: revenue $27.1M (+170% year over year), operating margin -94.5%, net loss $22.6M, operating cash flow −$3.4M. The chart follows the revenue to costs, profit and cash.
| Q1 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $27.1M | -13% | +170% |
| Operating profit | −$25.6M | — | — |
| Net earnings | −$22.6M | — | — |
| Operating cash flow | −$3.4M | — | — |
What changed
Revenue was $27.1M in Q1 2025, up 170% year over year and down 13% from the previous quarter.
Operating costs exceeded revenue by $25.6M, an operating margin of -94.5%. Total costs grew 10% against revenue growth of 170%. The fastest-growing cost line was Research & development (+12%). The quarter ended with a net loss of $22.6M, narrower than the previous quarter's $23.5M loss.
Operating cash flow was −$3.4M. Non-cash charges added back $2.6M of depreciation and amortization and $6.4M of share-based compensation. Working capital and other items added $10.2M. Capital expenditures of $16K exceeded it, leaving free cash flow of −$3.4M.
Questions
What was Zymeworks' revenue in the first quarter 2025?
Zymeworks (ZYME) reported revenue of $27.1M for the first quarter 2025 (Q1 2025), +170% from a year earlier and -13% from the quarter before.
Was Zymeworks profitable in the first quarter 2025?
Operating loss was $25.6M (-94.5% of revenue) and net loss $22.6M.
Source: Zymeworks 10-Q on SEC EDGAR.